US2019070196A1PendingUtilityA1
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Est. expiryApr 15, 2025(expired)· nominal 20-yr term from priority
A61P 5/24A61P 5/26A61P 43/00A61P 15/00A61P 15/16A61K 9/1075A61K 9/50A61K 47/14A61K 9/4858A61K 9/0053A61K 47/44A61K 45/00C07J 1/00A61K 47/10A61K 31/22A61K 31/568A61K 31/573A61K 47/26A61K 9/06A61K 47/12A61K 9/20
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
Claims
exact text as granted — not AI-modified1 .- 7 . (canceled)
8 . An oral pharmaceutical composition comprising a
(a) means for providing a serum testosterone ranging from about 300 to about 1100 ng/dL; and (b) a pharmaceutically acceptable carrier.
9 . The pharmaceutical composition of claim 8 , wherein the means for providing a serum testosterone ranging from about 300 to about 1100 ng/dL is a testosterone ester.
10 . The pharmaceutical composition of claim 9 , wherein the testosterone ester is chosen from testosterone palmitate, testosterone enanthate; testosterone undecanoate; testosterone cypionate.Join the waitlist — get patent alerts
Track US2019070196A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.